How to Check If Your Chemotherapy Drug — Is Approved in India

CDSCO is the Central Drugs Standard Control Organisation, the Indian national regulatory authority for medicines, under the Ministry of Health and Family Welfare. It approves every medicine sold or used in India, including all chemotherapy drugs. Without a CDSCO licence, a drug cannot legally be prescribed or administered in an Indian hospital. Approval requires the manufacturer to prove safety and efficacy, and to demonstrate that production meets Good Manufacturing Practice standards.

Search the SUGAM portal — the online database maintained by CDSCO — using the drug's generic name and, where you know it, the manufacturer's name. An approved product will appear with its licence details. Your hospital pharmacy is also required to hold documentation of approval for every drug it dispenses; asking to see it is a reasonable request that should be straightforward to fulfil.

No, when the generic holds CDSCO approval. A generic chemotherapy drug must demonstrate to CDSCO that it contains the same active ingredient at equivalent potency, manufactured under the same Good Manufacturing Practice standards as the original. The lower price reflects that the generic manufacturer did not repeat the original research — not that the regulatory bar was lower. CDSCO does not accept a reduced standard for generic applications.

A generic contains the same small-molecule active ingredient as the original and must demonstrate chemical equivalence. A biosimilar is a version of a biologically derived medicine — made from living cells — and must demonstrate that it is highly similar to the original biological product. Because biological medicines are inherently more complex, the approval process for biosimilars involves additional analytical and clinical testing compared to small-molecule generics. Both require CDSCO approval and both must meet Good Manufacturing Practice standards.

The price gap between a branded and a generic chemotherapy drug is normal. The branded originator price reflects years of research, clinical trials, and registration — costs the generic manufacturer does not repeat. Both versions must be CDSCO-approved to be sold legally in India. A lower price is not itself a warning sign. The warning signs are specific: a missing batch number, a missing manufacturer name, no Schedule H or H1 marking, or a product that cannot be found on the SUGAM portal under the manufacturer's name printed on the label.

Tell the nurse or pharmacist before the drug is administered, not after. Chemotherapy drugs can legitimately appear different — a different approved formulation, or a different manufacturer making the same molecule — and a changed appearance is not always a problem. But you cannot know that without asking. If the label is different, the manufacturer has changed, or something seems wrong, say so immediately. Your concern will be checked. You do not need to know the answer yourself — you need to ask the question.